Skip to main content
ST

SONIRE Therapeutics Inc.

The startup develops high-intensity focused ultrasound therapy systems that provide precise tissue targeting and real-time imaging for cancer treatment. This technology enhances treatment accuracy and patient comfort while addressing the limitations of traditional invasive surgical methods.

Tokyo, JapanFounded 20206300+ followers
Updated 20 months ago

Funding

$21.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

FTI
Funding rounds are not available yet.

Founders

Product

Problem

Traditional invasive surgical methods for cancer treatment can be limited by their lack of precision, potential for damage to surrounding healthy tissue, and longer recovery times for patients. These limitations can lead to increased complications and reduced quality of life for cancer patients.

Solution

The startup develops high-intensity focused ultrasound (HIFU) therapy systems that offer precise tissue targeting and real-time imaging capabilities for cancer treatment. This non-invasive technology allows clinicians to target and ablate cancerous tissue with greater accuracy, minimizing damage to surrounding healthy tissue. The real-time imaging provides enhanced visualization and control during the procedure, leading to improved treatment outcomes and patient comfort. By addressing the limitations of traditional surgical methods, the HIFU system offers a less invasive and more targeted approach to cancer treatment.

Target Audience

The primary target audience includes oncologists, radiologists, and hospitals specializing in cancer treatment, as well as patients seeking less invasive treatment options.

Features

  • High-intensity focused ultrasound (HIFU) technology for non-invasive tissue ablation
  • Real-time imaging guidance for precise targeting and monitoring
  • Customizable treatment parameters for different cancer types and locations
  • Integrated control system for precise energy delivery and tissue targeting
  • Non-invasive procedure, reducing the risk of complications and recovery time
  • Enhanced patient comfort compared to traditional surgical methods
This profile is AI-generated and may contain inaccuracies.